Yu Chen Barrett

About Yu Chen Barrett

Committed medical scientist with over 18 years\' experience in pharmaceutical companies (8 years in Clinical Development and 10 years in Medical Affairs) • Medical Affair strategy in Rare Diseases, Hematology, Cardiovascular, Respiratory, and Metabolics• US Medical Lead to launch or prepare to launch of 5 assets: Cablivi for TTP, Canakinumab for CVD, Fevipiprant for Asthma, Qtern for T2DM, Eliquis for AF• WW Medical Lead to prepare to lanuch: Camzyos (mavacamten for HOCM)• Medical lead for potential partnership and new product/technology acquisition (BD & L) • Matrix and functional team lead for multiple medical teams

Experience

1. Ww and Us Disease Area Head, Cardiomyopathy, Global Medical Affairs

   Bristol Myers Squibb

   Jun 2021 — Present · Princeton, NJ, US

   o World Wide and US Medical Disease Area Head, cardiomyopathy portfolio, including Mavacamten and other pipeline products o Responsible for regulatory approval and launch of Camzyos (mavacamten) over 50 countries globally o Develop and execute the WW medical plan, incorporate medical insights into strategy, provide strategic directions in scientific communication, deliver key knowledge to country medical colleagues, facilitate best practice sharing among countries, ensure global and local strategic alignmento Drive an integrated strategy and communication platform, ensuring optimized and aligned thought leader interactions and seamless coordinated communications both internally and externallyo Responsible for regulatory filling activities on behalf of WW medical for all regions including label review and negations, safety assessments, and risk mitigation strategy o Tour of duty to China responsible for integration of a Chinese biotech to BMS: set up new CV medical team in China; guide the development of Mavacamten launch plan in China o Establish linkages across all major functions (e.g. Development, R&D, HEOR, Value Access & Pricing, Regulatory, Commercial, Corporate Affairs, etc.) and build alignment with cross-functional partners o Ensure WW medical strategy is incorporated in key market regulatory filling and label negotiations o Establish and maintain ongoing long-term collaborative peer-to-peer relationships with key thought leaders and manages WW Key Opinion Leader activities (e.g, ad boards, medical symposium, KOL encounters)

Education

• University of New Hampshire

  Ph. D., Biochemistry

Skills

• Biomarkers
• Pharmacology
• Clinical Development
• Assay Development
• Oncology
• Medical Affairs
• Fda
• Drug Development
• Clinical Trials
• Elisa
• Drug Metabolism
• Pharmacodynamics
• Translational Medicine